Phase 2 Study of Oral IXAZOMIB in Adult Patients With Relapsed and/or Refractory Follicular Lymphoma
This study has been completed.
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Takeda ( Millennium Pharmaceuticals, Inc. )
First received: August 28, 2013
Last updated: March 28, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||March 23, 2017|
|Primary Completion Date:||June 1, 2016 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||November 29, 2016|